These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 24393614)

  • 1. Increased levels of the oxidative stress marker, nitrotyrosine in patients with provocation test-induced coronary vasospasm.
    Tanabe K; Kawai Y; Kitayama M; Akao H; Ishida R; Motoyama A; Wakasa M; Saito R; Aoki H; Fujibayashi K; Watanabe M; Tsuchiya T; Kimura H; Yoshida K; Kajinami K
    J Cardiol; 2014 Aug; 64(2):86-90. PubMed ID: 24393614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum deoxyribonuclease I activity can be used as a novel marker of transient myocardial ischaemia: results in vasospastic angina pectoris induced by provocation test.
    Morikawa N; Kawai Y; Arakawa K; Kumamoto T; Miyamori I; Akao H; Kitayama M; Kajinami K; Lee JD; Takeshita H; Kominato Y; Yasuda T
    Eur Heart J; 2007 Dec; 28(24):2992-7. PubMed ID: 17967825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical usefulness, angiographic characteristics, and safety evaluation of intracoronary acetylcholine provocation testing among 921 consecutive white patients with unobstructed coronary arteries.
    Ong P; Athanasiadis A; Borgulya G; Vokshi I; Bastiaenen R; Kubik S; Hill S; Schäufele T; Mahrholdt H; Kaski JC; Sechtem U
    Circulation; 2014 Apr; 129(17):1723-30. PubMed ID: 24573349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Disease activities and serum C-reactive protein levels in patients with vasospastic angina pectoris].
    Katayama N; Nakao K; Horiuchi K; Kasanuki H; Honda T
    J Cardiol; 2005 Aug; 46(2):63-70. PubMed ID: 16127895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum deoxyribonuclease I can be used as a useful marker for diagnosis of death due to ischemic heart disease.
    Yasuda T; Iida R; Kawai Y; Nakajima T; Kominato Y; Fujihara J; Takeshita H
    Leg Med (Tokyo); 2009 Apr; 11 Suppl 1():S213-5. PubMed ID: 19254870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Bronchial hyperresponsiveness in patients with vasospastic angina pectoris (VSAP)].
    Kageshita T; Nishimura Y; Nakata H; Terashima M; Kajiura T; Maeda H; Yokoyama M
    Nihon Kyobu Shikkan Gakkai Zasshi; 1997 Oct; 35(10):1035-9. PubMed ID: 9465612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myocardial sympathetic denervation, fatty acid metabolism, and left ventricular wall motion in vasospastic angina.
    Watanabe K; Takahashi T; Miyajima S; Hirokawa Y; Tanabe N; Kato K; Kodama M; Aizawa Y; Tazawa S; Inoue M
    J Nucl Med; 2002 Nov; 43(11):1476-81. PubMed ID: 12411551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bronchial hyperresponsiveness to acetylcholine in patients with vasospastic angina pectoris.
    Saitoh Y; Sasaki F; Ishizaki T; Miyabo S; Kanamori K; Mifune J
    Chest; 1994 Feb; 105(2):364-7. PubMed ID: 8306729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ischemia-modified albumin is a highly sensitive serum marker of transient myocardial ischemia induced by coronary vasospasm.
    Cho DK; Choi JO; Kim SH; Choi J; Rhee I; Ki CS; Lee SC; Gwon HC
    Coron Artery Dis; 2007 Mar; 18(2):83-7. PubMed ID: 17301598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased plasma glutamate in non-smokers with vasospastic angina pectoris is associated with plasma cystine and antioxidant capacity.
    Oda M; Fujibayashi K; Wakasa M; Takano S; Fujita W; Kitayama M; Nakanishi H; Saito K; Kawai Y; Kajinami K
    Scand Cardiovasc J; 2022 Dec; 56(1):180-186. PubMed ID: 35695518
    [No Abstract]   [Full Text] [Related]  

  • 11. Malondialdehyde-Modified Low Density Lipoprotein as Oxidative-Stress Marker in Vasospastic Angina Patients.
    Oumi T; Nozato T; Sakakibara A; Nomoto H; Ohno M; Takahashi Y; Ashikaga T; Satoh Y; Isobe M
    Int Heart J; 2017 May; 58(3):335-343. PubMed ID: 28539572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reversible ischemia on treadmill exercise in left main coronary artery vasospasm.
    Hung MY; Chang NC; Hung MJ
    Chin Med J (Engl); 2011 Dec; 124(24):4364-7. PubMed ID: 22340417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of clinical characteristics and prognosis in Taiwanese patients with coronary vasospastic angina pectoris without significant fixed coronary artery disease versus patients with significant fixed coronary artery disease and either stable angina pectoris or acute coronary syndromes.
    Hung MJ; Hung MY; Cheng CW; Yang NI; Cherng WJ
    Am J Med Sci; 2007 Sep; 334(3):160-7. PubMed ID: 17873528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical significance of plasma concentration of macrophage colony-stimulating factor in patients with vasospastic angina].
    Tomimura M; Saitoh T; Kishida H; Kusama Y; Takano T
    J Cardiol; 2002 Jan; 39(1):19-27. PubMed ID: 11828794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vasospastic angina pectoris associated with Churg-Strauss syndrome.
    Petrakopoulou P; Franz WM; Boekstegers P; Weis M
    Nat Clin Pract Cardiovasc Med; 2005 Sep; 2(9):484-9; quiz 490. PubMed ID: 16265589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Letter by Mohri regarding article, "Clinical usefulness, angiographic characteristics, and safety evaluation of intracoronary acetylcholine provocation testing among 921 consecutive white patients with unobstructed coronary arteries".
    Mohri M
    Circulation; 2015 Jan; 131(4):e324. PubMed ID: 25623131
    [No Abstract]   [Full Text] [Related]  

  • 17. Response to letters regarding article, "Clinical usefulness, angiographic characteristics, and safety evaluation of intracoronary acetylcholine provocation testing among 921 consecutive white patients with unobstructed coronary arteries".
    Ong P; Athanasiadis A; Borgulya G; Vokshi I; Bastiaenen R; Kubik S; Hill S; Schäufele T; Mahrholdt H; Kaski JC; Sechtem U
    Circulation; 2015 Jan; 131(4):e325. PubMed ID: 25623132
    [No Abstract]   [Full Text] [Related]  

  • 18. Letter by Yasue et al regarding article, "Clinical usefulness, angiographic characteristics, and safety evaluation of intracoronary acetylcholine provocation testing among 921 consecutive white patients with unobstructed coronary arteries".
    Yasue H; Mizuno Y; Harada E
    Circulation; 2015 Jan; 131(4):e323. PubMed ID: 25623130
    [No Abstract]   [Full Text] [Related]  

  • 19. Sequential spasm provocation tests might overcome a limitation of the standard spasm provocation tests.
    Sueda S; Miyoshi T; Sasaki Y; Sakaue T; Habara H; Kohno H
    Coron Artery Dis; 2015 Sep; 26(6):490-4. PubMed ID: 25974266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of serum levels of inflammatory markers in patients with coronary vasospasm without significant fixed coronary artery disease versus patients with stable angina pectoris and acute coronary syndromes with significant fixed coronary artery disease.
    Hung MJ; Cherng WJ; Cheng CW; Li LF
    Am J Cardiol; 2006 May; 97(10):1429-34. PubMed ID: 16679078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.